Birchview Capital as of March 31, 2018
Portfolio Holdings for Birchview Capital
Birchview Capital holds 49 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 41.7 | $63M | 709k | 89.21 | |
| Accelr8 Technology | 32.9 | $50M | 2.2M | 22.85 | |
| Neurocrine Biosciences (NBIX) | 2.9 | $4.3M | 52k | 82.94 | |
| Vermillion | 2.1 | $3.2M | 2.4M | 1.36 | |
| Oxford Immunotec Global | 1.4 | $2.2M | 177k | 12.45 | |
| EQT Corporation (EQT) | 1.3 | $2.0M | 42k | 47.52 | |
| Contrafect | 1.2 | $1.9M | 1.1M | 1.63 | |
| Array BioPharma | 1.2 | $1.8M | 112k | 16.32 | |
| Quidel Corporation | 1.2 | $1.8M | 34k | 51.80 | |
| Vanda Pharmaceuticals (VNDA) | 1.0 | $1.5M | 88k | 16.85 | |
| Encana Corp | 1.0 | $1.5M | 132k | 11.00 | |
| Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.2M | 76k | 16.45 | |
| Soleno Therapeutics | 0.8 | $1.2M | 678k | 1.81 | |
| Acceleron Pharma | 0.6 | $978k | 25k | 39.12 | |
| Atara Biotherapeutics | 0.6 | $897k | 23k | 39.00 | |
| G1 Therapeutics | 0.5 | $815k | 22k | 37.05 | |
| Albireo Pharma | 0.5 | $782k | 24k | 32.58 | |
| Masimo Corporation (MASI) | 0.5 | $704k | 8.0k | 88.00 | |
| Axogen (AXGN) | 0.4 | $657k | 18k | 36.50 | |
| Veracyte (VCYT) | 0.4 | $660k | 119k | 5.56 | |
| Voyager Therapeutics (VYGR) | 0.4 | $620k | 33k | 18.79 | |
| Sientra | 0.4 | $611k | 63k | 9.65 | |
| Wright Medical | 0.4 | $595k | 30k | 19.83 | |
| Clementia | 0.4 | $576k | 38k | 15.16 | |
| Sito Mobile (STTO) | 0.4 | $563k | 140k | 4.02 | |
| Biogen Idec (BIIB) | 0.4 | $548k | 2.0k | 274.00 | |
| Biolase Technology | 0.3 | $527k | 1.3M | 0.41 | |
| Yield10 Bioscience | 0.3 | $528k | 271k | 1.95 | |
| Pioneer Natural Resources | 0.3 | $515k | 3.0k | 171.67 | |
| Amicus Therapeutics (FOLD) | 0.3 | $511k | 34k | 15.03 | |
| Tesaro | 0.3 | $469k | 8.2k | 57.20 | |
| Dicerna Pharmaceuticals | 0.3 | $430k | 45k | 9.56 | |
| Shire | 0.3 | $403k | 2.7k | 149.26 | |
| Arena Pharmaceuticals | 0.3 | $395k | 10k | 39.50 | |
| Xencor (XNCR) | 0.2 | $369k | 12k | 30.00 | |
| Oncomed Pharmaceuticals | 0.2 | $314k | 99k | 3.18 | |
| Myriad Genetics (MYGN) | 0.2 | $296k | 10k | 29.60 | |
| AVEO Pharmaceuticals | 0.2 | $290k | 100k | 2.90 | |
| Ablynx Nv | 0.2 | $273k | 5.0k | 54.60 | |
| Clovis Oncology | 0.2 | $264k | 5.0k | 52.80 | |
| Intercept Pharmaceuticals In | 0.2 | $265k | 4.3k | 61.63 | |
| Aevi Genomic | 0.2 | $257k | 128k | 2.01 | |
| Genocea Biosciences | 0.1 | $199k | 189k | 1.05 | |
| Quotient | 0.1 | $187k | 40k | 4.71 | |
| Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.1 | $154k | 10k | 15.40 | |
| Solid Biosciences | 0.1 | $150k | 20k | 7.50 | |
| Workhorse Group Inc ordinary shares | 0.1 | $132k | 50k | 2.64 | |
| Celgene Corp right 12/31/2011 | 0.1 | $70k | 242k | 0.29 | |
| Cytokinetics (CYTK) | 0.1 | $72k | 10k | 7.20 |
